FDA Issues Two AI-Related Draft Guidance Documents for Drugs, Medical Devices
- January 10, 2025
The Food and Drug Administration (FDA) issued January 6 two draft guidance documents that address the use of artificial intelligence (AI) in developing drugs and medical devices.
ARTICLE TAGS
You must be logged in to access this content.